Design and synthesis of imidazo[1,2-a]pyridine-chalcone conjugates as antikinetoplastid agents. 2024

Devesh S Agarwal, and Richard M Beteck, and Kayhan Ilbeigi, and Guy Caljon, and Lesetja J Legoabe
Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa.

A library of imidazo[1,2-a]pyridine-appended chalcones were synthesized and characterized using 1 H NMR, 13 C NMR and HRMS. The synthesized analogues were screened for their antikinetoplastid activity against Trypanosoma cruzi, Trypanosoma brucei brucei, Trypanosoma brucei rhodesiense and Leishmania infantum. The analogues were also tested for their cytotoxicity activity against human lung fibroblasts and primary mouse macrophages. Among all screened derivatives, 7f was found to be the most active against T. cruzi and T. b. brucei exhibiting IC50 values of 8.5 and 1.35 μM, respectively. Against T. b. rhodesiense, 7e was found to be the most active with an IC50 value of 1.13 μM. All synthesized active analogues were found to be non-cytotoxic against MRC-5 and PMM with selectivity indices of up to more than 50.

UI MeSH Term Description Entries
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002599 Chalcone An aromatic KETONE that forms the core molecule of CHALCONES. Benzalacetophenone,Benzylideneacetophenone,1,3-Diphenyl-2-Propen-1-One,Chalkone,1,3 Diphenyl 2 Propen 1 One
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000981 Antiprotozoal Agents Substances that are destructive to protozoans. Schizonticides,Agents, Antiprotozoal
D014344 Trypanocidal Agents Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. Trypanocidal Drugs,Trypanocides,Trypanosomicidal Agents,Trypanosomicides,Agents, Trypanocidal,Agents, Trypanosomicidal,Drugs, Trypanocidal
D014346 Trypanosoma brucei brucei A hemoflagellate subspecies of parasitic protozoa that causes nagana in domestic and game animals in Africa. It apparently does not infect humans. It is transmitted by bites of tsetse flies (Glossina). Trypanosoma brucei,Trypanosoma brucei bruceus,Trypanosoma bruceus,brucei brucei, Trypanosoma,brucei, Trypanosoma brucei,bruceus, Trypanosoma,bruceus, Trypanosoma brucei
D014349 Trypanosoma cruzi The agent of South American trypanosomiasis or CHAGAS DISEASE. Its vertebrate hosts are man and various domestic and wild animals. Insects of several species are vectors. Trypanosoma cruzus,cruzi, Trypanosoma
D014355 Chagas Disease Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON. Trypanosomiasis, South American,American Trypanosomiasis,Chagas' Disease,Trypanosoma cruzi Infection,Infection, Trypanosoma cruzi,Infections, Trypanosoma cruzi,South American Trypanosomiasis,Trypanosoma cruzi Infections,Trypanosomiasis, American
D047188 Chalcones Derivatives of CHALCONE that are important intermediates in the formation of FLAVONOIDS with anti-fungal, anti-bacterial, anti-inflammatory, and anti-tumor properties. 1,3-Diphenyl-propanediones,1,3-Diphenyl-propenones,1,3-Diphenylpropanediones,1,3-Diphenylpropenones,Chalconoids,1,3 Diphenyl propanediones,1,3 Diphenyl propenones,1,3 Diphenylpropanediones,1,3 Diphenylpropenones

Related Publications

Devesh S Agarwal, and Richard M Beteck, and Kayhan Ilbeigi, and Guy Caljon, and Lesetja J Legoabe
January 2001, Arzneimittel-Forschung,
Devesh S Agarwal, and Richard M Beteck, and Kayhan Ilbeigi, and Guy Caljon, and Lesetja J Legoabe
December 2014, ChemMedChem,
Devesh S Agarwal, and Richard M Beteck, and Kayhan Ilbeigi, and Guy Caljon, and Lesetja J Legoabe
January 2017, Current topics in medicinal chemistry,
Devesh S Agarwal, and Richard M Beteck, and Kayhan Ilbeigi, and Guy Caljon, and Lesetja J Legoabe
June 2021, Pesticide biochemistry and physiology,
Devesh S Agarwal, and Richard M Beteck, and Kayhan Ilbeigi, and Guy Caljon, and Lesetja J Legoabe
September 1972, Journal of medicinal chemistry,
Devesh S Agarwal, and Richard M Beteck, and Kayhan Ilbeigi, and Guy Caljon, and Lesetja J Legoabe
March 2022, RSC medicinal chemistry,
Devesh S Agarwal, and Richard M Beteck, and Kayhan Ilbeigi, and Guy Caljon, and Lesetja J Legoabe
January 2024, Anti-cancer agents in medicinal chemistry,
Devesh S Agarwal, and Richard M Beteck, and Kayhan Ilbeigi, and Guy Caljon, and Lesetja J Legoabe
April 2023, RSC medicinal chemistry,
Devesh S Agarwal, and Richard M Beteck, and Kayhan Ilbeigi, and Guy Caljon, and Lesetja J Legoabe
September 2019, European journal of medicinal chemistry,
Devesh S Agarwal, and Richard M Beteck, and Kayhan Ilbeigi, and Guy Caljon, and Lesetja J Legoabe
December 2010, European journal of medicinal chemistry,
Copied contents to your clipboard!